-
Something wrong with this record ?
Cytotoxicity and induction of apoptosis by 4-amino-3-acetylquinoline in murine leukemia cell line L1210
A. Repický, S. Jantová, M. Theiszová, V. Milata
Language English Country Czech Republic
Document type Journal Article, Research Support, Non-U.S. Gov't
NLK
Directory of Open Access Journals
from 2001
Free Medical Journals
from 1998
ROAD: Directory of Open Access Scholarly Resources
from 2001
PubMed
16601785
DOI
10.5507/bp.2005.055
Knihovny.cz E-resources
- MeSH
- Apoptosis drug effects MeSH
- Quinolines pharmacology MeSH
- Leukemia L1210 pathology MeSH
- Mice MeSH
- Tumor Cells, Cultured MeSH
- Cell Proliferation drug effects MeSH
- Antineoplastic Agents pharmacology MeSH
- Drug Screening Assays, Antitumor MeSH
- Animals MeSH
- Check Tag
- Mice MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
Nitrogen heterocyclic compounds are used in the pharmaceutical industry, in medicine and in agriculture for their biological activity. 4-Amino-3-acetylquinoline, a new synthetically prepared quinoline derivative, was the most effective compound in our primary cytotoxic screening. In this study, we evaluated cytotoxic/antiproliferative activity of quinoline using murine leukemia cell line L1210. Its ability to induce apoptosis was studied, too. Quinoline derivative acted cytotoxically on tumor cell line L1210, the IC(100) value were 50 microg/ml (for 24 h), 25 microg/ml (for 48 h) and 10 microg/ml (for 72 h). The IC(50) values was found to be less than 4 microg/ml, a limit put forward by the National Cancer Institute (NCI) for classification of he compound as a potential anticancer drug. The cytotoxic concentrations of 4-amino-3-acetyl quinoline induced morphological changes of L1210 cells and the apoptotic DNA fragmentation.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13003743
- 003
- CZ-PrNML
- 005
- 20171120073901.0
- 007
- ta
- 008
- 130128s2005 xr d f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.5507/bp.2005.055 $2 doi
- 035 __
- $a (PubMed)16601785
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Repický, Andrej $7 xx0106035 $u Department of Biochemistry and Microbiology, Slovak University of Technology, Bratislava
- 245 10
- $a Cytotoxicity and induction of apoptosis by 4-amino-3-acetylquinoline in murine leukemia cell line L1210 / $c A. Repický, S. Jantová, M. Theiszová, V. Milata
- 520 9_
- $a Nitrogen heterocyclic compounds are used in the pharmaceutical industry, in medicine and in agriculture for their biological activity. 4-Amino-3-acetylquinoline, a new synthetically prepared quinoline derivative, was the most effective compound in our primary cytotoxic screening. In this study, we evaluated cytotoxic/antiproliferative activity of quinoline using murine leukemia cell line L1210. Its ability to induce apoptosis was studied, too. Quinoline derivative acted cytotoxically on tumor cell line L1210, the IC(100) value were 50 microg/ml (for 24 h), 25 microg/ml (for 48 h) and 10 microg/ml (for 72 h). The IC(50) values was found to be less than 4 microg/ml, a limit put forward by the National Cancer Institute (NCI) for classification of he compound as a potential anticancer drug. The cytotoxic concentrations of 4-amino-3-acetyl quinoline induced morphological changes of L1210 cells and the apoptotic DNA fragmentation.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a protinádorové látky $x farmakologie $7 D000970
- 650 _2
- $a apoptóza $x účinky léků $7 D017209
- 650 _2
- $a proliferace buněk $x účinky léků $7 D049109
- 650 _2
- $a screeningové testy protinádorových léčiv $7 D004354
- 650 _2
- $a leukemie L1210 $x patologie $7 D007939
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a chinoliny $x farmakologie $7 D011804
- 650 _2
- $a nádorové buňky kultivované $7 D014407
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1#
- $a Jantová, Soňa. $7 mzk2010566685 $u Department of Biochemistry and Microbiology, Slovak University of Technology, Bratislava
- 700 1#
- $a Theiszová, Marica. $7 _AN071556 $u Department of Biochemistry and Microbiology, Slovak University of Technology, Bratislava
- 700 1_
- $a Milata, Viktor, $d 1957- $7 mzk2004258503 $u Department of Organic Chemistry, Faculty of Chemical and Food Technology, Slovak University of Technology, Bratislava
- 773 0_
- $w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacký, Olomouc, Czech Republic $x 1213-8118 $g Roč. 149, č. 2 (2005), s. 345-347
- 910 __
- $a ABA008 $b A 1502 $c sign $y 3 $z 0
- 990 __
- $a 20130128 $b ABA008
- 991 __
- $a 20171120074018 $b ABA008
- 999 __
- $a ok $b bmc $g 966399 $s 801938
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2005 $b 149 $c 2 $d 345-347 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
- LZP __
- $b NLK111 $a Pubmed-20130128